741 |
Assessment of Myocardial Viability |
James K. Min |
May. 15. 12 |
740 |
New Devices for Treatment of CLI: What Works, What Doesn\'t |
Michael R. Jaff |
May. 15. 12 |
739 |
Angiosome Principle and Case-based Strategy for BTK Procedure |
Kazushi Urasawa |
May. 15. 12 |
738 |
When Outcomes Matter, Design Matter |
William A. Gray |
May. 15. 12 |
737 |
Pharmacogenomics of Clopidogrel and Its Correlation with Clinical Outcomes |
Jung-Won Suh |
May. 15. 12 |
736 |
Polyvascular Disease & Broad Indication of Clopidogrel |
Sang Hyun Kim |
May. 15. 12 |
735 |
Triple Antiplatelet Therapy in DES Era: Default Strategy in High Risk Population |
Seung-Whan Lee |
May. 15. 12 |
734 |
The Limits of Platelet Oriented Treatment : Cilostazol as Multidisciplinary Approach |
Young-Hoon Jeong |
May. 15. 12 |
733 |
PtCr EES, Beyond Promus Element: Promus Element Plus & Synergy |
Ian T. Meredith |
May. 15. 12 |
732 |
Promus Element Clinical Program in Asan Medical Center |
Jung-Min Ahn |
May. 15. 12 |